RegentAtlantic Capital’s Universal Health Services UHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $390K | Sell |
4,423
-518
| -10% | -$53.5K | 0.01% | 507 |
|
|
2022
Q2 | $498K | Sell |
4,941
-853
| -15% | -$107K | 0.02% | 436 |
|
|
2022
Q1 | $840K | Sell |
5,794
-392
| -6% | -$54.2K | 0.02% | 350 |
|
|
2021
Q4 | $802K | Sell |
6,186
-427
| -6% | -$54.9K | 0.02% | 359 |
|
|
2021
Q3 | $915K | Sell |
6,613
-339
| -5% | -$51.3K | 0.03% | 319 |
|
|
2021
Q2 | $1.02M | Sell |
6,952
-226
| -3% | -$34.2K | 0.03% | 292 |
|
|
2021
Q1 | $957K | Sell |
7,178
-874
| -11% | -$116K | 0.03% | 283 |
|
|
2020
Q4 | $1.11M | Sell |
8,052
-413
| -5% | -$51.4K | 0.04% | 230 |
|
|
2020
Q3 | $906K | Sell |
8,465
-2,362
| -22% | -$253K | 0.04% | 246 |
|
|
2020
Q2 | $1.01M | Sell |
10,827
-811
| -7% | -$81.1K | 0.06% | 220 |
|
|
2020
Q1 | $1.15M | Buy |
11,638
+676
| +6% | +$85.6K | 0.09% | 189 |
|
|
2019
Q4 | $1.57M | Buy |
10,962
+666
| +6% | +$94.9K | 0.1% | 192 |
|
|
2019
Q3 | $1.53M | Buy |
10,296
+250
| +2% | +$35.9K | 0.1% | 191 |
|
|
2019
Q2 | $1.31M | Buy |
10,046
+852
| +9% | +$107K | 0.09% | 204 |
|
|
2019
Q1 | $1.23M | Buy |
9,194
+591
| +7% | +$77.8K | 0.09% | 207 |
|
|
2018
Q4 | $1M | Buy |
8,603
+1,304
| +18% | +$164K | 0.09% | 212 |
|
|
2018
Q3 | $933K | Buy |
7,299
+355
| +5% | +$43.6K | 0.07% | 233 |
|
|
2018
Q2 | $774K | Buy |
6,944
+455
| +7% | +$53.3K | 0.07% | 242 |
|
|
2018
Q1 | $768K | Buy |
6,489
+10
| +0.2% | +$1.19K | 0.06% | 238 |
|
|
2017
Q4 | $734K | Buy |
6,479
+795
| +14% | +$85K | 0.06% | 251 |
|
|
2017
Q3 | $631K | Buy |
5,684
+225
| +4% | +$25.3K | 0.05% | 257 |
|
|
2017
Q2 | $666K | Buy |
5,459
+54
| +1% | +$6.43K | 0.06% | 245 |
|
|
2017
Q1 | $673K | Sell |
5,405
-29
| -0.5% | -$3.43K | 0.06% | 242 |
|
|
2016
Q4 | $578K | Sell |
5,434
-119
| -2% | -$14.1K | 0.06% | 263 |
|
|
2016
Q3 | $684K | Hold |
5,553
| – | – | 0.07% | 236 |
|
|
2016
Q2 | $745K | Sell |
5,553
-170
| -3% | -$22.4K | 0.07% | 223 |
|
|
2016
Q1 | $714K | Buy |
5,723
+10
| +0.2% | +$1.13K | 0.08% | 207 |
|
|
2015
Q4 | $683K | Hold |
5,713
| – | – | 0.07% | 230 |
|
|
2015
Q3 | $713K | Sell |
5,713
-580
| -9% | -$80.7K | 0.07% | 216 |
|
|
2015
Q2 | $894K | Sell |
6,293
-240
| -4% | -$30.1K | 0.08% | 193 |
|
|
2015
Q1 | $769K | Sell |
6,533
-295
| -4% | -$32.6K | 0.07% | 214 |
|
|
2014
Q4 | $760K | Sell |
6,828
-685
| -9% | -$71.9K | 0.06% | 212 |
|
|
2014
Q3 | $785K | Sell |
7,513
-80
| -1% | -$8.5K | 0.07% | 202 |
|
|
2014
Q2 | $727K | Hold |
7,593
| – | – | 0.07% | 209 |
|
|
2014
Q1 | $623K | Sell |
7,593
-90
| -1% | -$7.24K | 0.06% | 221 |
|
|
2013
Q4 | $624K | Sell |
7,683
-40
| -0.5% | -$3.2K | 0.06% | 225 |
|
|
2013
Q3 | $579K | Sell |
7,723
-100
| -1% | -$6.98K | 0.06% | 216 |
|
|
2013
Q2 | $524K | Buy |
+7,823
| New | +$517K | 0.06% | 219 |
|
Other funds holding UHS
CCM
NI
RegentAtlantic Capital's UHS Position: Q3 2022 in Review
RegentAtlantic Capital reduced its Universal Health Services (UHS) stake by 10% in Q3 2022, selling an estimated $53.5K and leaving 4,423 shares worth $390K. The position accounts for 0.01% of the portfolio, ranked #507.
RegentAtlantic Capital first reported a position in UHS in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.57M in Q4 2019. 426 funds tracked by Wall St. Rank hold UHS as of Q3 2022.
- RegentAtlantic Capital held 4,423 shares of Universal Health Services worth $390K as of Q3 2022.
- RegentAtlantic Capital sold 518 Universal Health Services shares in Q3 2022, an estimated $53.5K.
- Universal Health Services made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #507 holding.
- RegentAtlantic Capital first reported a position in Universal Health Services in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Universal Health Services position peaked at $1.57M in Q4 2019.
- 426 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.